SanDiegOmics
Private Company
Funding information not available
Overview
SanDiegOmics is a boutique consultancy leveraging over 25 years of founder expertise to guide clients through the complex genomics and sequencing landscape. The firm offers strategic services such as market assessment, fundraising support, M&A due diligence, and expert witness testimony, positioning itself as a critical resource for investors and companies navigating technological disruption. Founded in 2018 and based in San Diego, it operates as a private, likely solo or very small practice, generating revenue through high-value consulting engagements rather than product sales.
Technology Platform
Proprietary market intelligence and analytical framework for genomics and sequencing technologies, including competitive landscape tracking, technical assessment, and market trend analysis.
Opportunities
Risk Factors
Competitive Landscape
Operates in a niche with few direct competitors offering the same depth of genomics-specific consulting. Competes indirectly with broad life science strategy units of large management consultancies (e.g., McKinsey, BCG) and boutique tech analysis firms. Its unique selling proposition is Dr. Baker's hands-on industry experience and historical perspective, which is difficult to replicate.